Use of Platelet Rich Plasma from Cord Blood Vs Placebo in the Treatment of Vulvar Lichen Sclerosus

Recruiting Phase 1 Phase 2 Interventional Study
Vulvar Lichen Sclerosus
Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Female
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Vulvar lichen Sclerosus (VLS) is a cutaneous-mucosal dermatosis that causes in the adult female vulvar itching and burning due to scratching abrasions. Dyspareunia is often associated . The areas most affected are the labia minora, the periclitoral area, the navicular dimple, and the perianal area. The placement of VLS in the context of immune-mediated dermatoses is the basis of the rationale for …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * women with VLS (clinical/histological diagnosis) * good health conditions * written informed consent signed and dated by the patient Exclusion Criteria: * pregnancy * coagulopathies, platelet disorders, cardiovascular and/or respiratory diseases * ongoing major infections * …
Contacts

Veronica Boero, MD

0255032318

veronica.boero@policlinico.mi.it

CONTACT